An outbreak of invasive infection caused by a highly encapsulated emm3 strain in Spain highlights the potential impact of a single virulence factor, in this case capsule, on invasiveness or transmission potential [18] . An increase in invasive disease in the UK in 2009 was related to a sudden increase in the proportion of cases associated with emm3 GAS isolates. The reasons for this remain unclear. The altered epidemiology was shortlived, and emm1 strains remain the prevalent cause of invasive GAS disease in the UK [12 ] .
Despite increasing our understanding of the characteristics of GAS infection by genome sequencing of individual emm types [19] , much remains to be elucidated regarding underlying molecular changes that might allow the evolution of highly virulent clones within specific emm types. Comparative genomic analysis of over 300 emm3 strains from three GAS epidemics in Ontario provided new information on bacterial population genetics [1] . These data show that GAS populations are not static, but formed of many subpopulations within specified emm types. Each epidemic was caused by a shift in GAS population dynamics resulting in the emergence of a subpopulation of emm3 strains within the previously immune community [1] . This may explain the traditional 4-7 yearly cycle of GAS epidemics. Intriguingly, the current emm1 GAS epidemic has persisted for over 25 years [3, 11] .
Molecular analysis of GAS strains currently circulating shows that invasive infection is mainly attributable to a hypervirulent clonal population of emm1 isolates [12 ,20-23] . The global spread of this clone, coupled with its association with both severe and self-limiting infections is unusual [3] .
A key feature of the emm1 clone is its ability to switch rapidly to a hypervirulent phenotype during infection [20, 21, [23] [24] [25] , as shown by transcriptional [20, 21, 24, 25] and proteomic analysis [23] . emm1 GAS strains have increased susceptibility to mutations in the CovR/S sensor protein, CovS [25] . The resulting transcriptional changes are vital to induce the characteristic hypervirulence of the currently circulating clone [22] .
Postpartum sepsis
The incidence of sepsis following childbirth has risen in recent years [12 ,26,27] . Of note is the rise across Europe and North America in abundance of emm28 strains which are associated with almost one-third of puerperal sepsis cases [12 ] . Genome sequencing has demonstrated that emm28 GAS strains have acquired an island of genetic material encoding adhesins similar to those found in Streptococcus agalactiae [19] , a frequent cause of intrapartum and vertically transmitted neonatal sepsis [28] ; these may facilitate colonization of the genital tract. However, whilst emm28 strains have a clear association with puerperal sepsis, an upsurge in mortality (recently highlighted in the United Kingdom by the Royal College of Obstetricians and Gynaecologists) appears more strongly associated with emm1 and to a lesser extent emm3 strains [12 ,27] .
Virulence factors
GAS possesses a variety of virulence factors, vital in enabling the establishment of infection in the host.
CovR/S
The CovR/S system is important in mediating the GAS stress response [29, 30] . It directs the transition from repression to derepression of major virulence genes during infection [31, 32] , and regulates up to 15% of the GAS genome.
CovS mutations are reported to be selected for by in-vivo immune pressures [25] . Such mutations are associated with loss of expression of the cysteine protease SpeB, which is responsible for autodegradation of a number of GAS virulence factors including Sda-1 and certain superantigens. Sda-1 is a newly described DNase characteristically present in modern emm1 strains; Sda-1 expression results in increased DNA degradation associated with the clearance of neutrophil extracellular traps and resistance to killing by phagocytes. CovS mutation therefore results in a hypervirulent phenotype by limiting autodegradation of a number of major GAS virulence factors ( Fig. 1 ) [25, 33] .
Apart from the impact of CovR/S mutations in emm1 strains, it is important to recognize that CovR/S dictates the potency of all GAS serotypes, through a universal impact on major virulence factors including the hyaluronic acid capsule [32] and the chemokine protease Spy-CEP [34 ] . The complexity of virulence gene regulation by CovR/S is illustrated by additional emm-type specific
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Key points
There has been a shift in prevalence of group A streptococcus (GAS) serotypes causing invasive disease, in particular strains of serotype emm1. Mutations in the CovR/S two-component system are inherently linked with the recent resurgence of invasive emm1 GAS. CRIPSRs are likely to be of key importance in the evolution of pathogenic bacteria. The rise in GAS antibiotic resistance and the continued morbidity and mortality associated with rheumatic fever highlight the need for an effective vaccine.
effects on other genes associated with virulence and invasiveness [35 ] . Furthermore, recent research has begun to unpick the relationship between CovR/S and other regulatory systems including the catabolite control protein (CcpA) [36, 37 ] , the regulatory protein Rgg [38 ] and the metal transporter of streptococcus regulator (MtsR) [15, 39] . These systems have overlapping regulatory patterns with CovR/S, but do not have the same universal impact on bacterial gene expression.
SpyCEP
The newly discovered serine protease SpyCEP expressed by all strains of Streptococcus pyogenes is CovR/S regulated [34 ] and can cleave and inactivate the entire repertoire of human neutrophil-recruiting chemokines including CXCL8/IL8 [40 ] . Recent work has shown SpyCEP to be both necessary and sufficient to cause dissemination of invasive GAS in vivo [41] . The observed increase in GAS virulence related to mutations in the CovR/S system is partly due to derepression of SpyCEP secretion [34 ] . Recent structure-function analysis of this cell envelope protease has shed light on unique features of this protease, suggesting that two separate domains combine to create a functional enzyme [40 ] .
Superantigens
Superantigens are powerful T-cell mitogens eliciting their effects by binding the MHC class II of antigenpresenting cells and the variable region of the T-cell receptor b-chain concomitantly. GAS strains make up to eleven superantigens (Table 1) , most possess four or five superantigen genes. Two further proteins identified as superantigens, SPEB and SPEF, are now known to function as a protease and a deoxyribonuclease, respectively, rather than superantigens [42, 43] . Indeed, SPEB may temper superantigen activity by degrading them [43] .
Recent epidemiological studies have found that SPEA, SPEJ and SMEZ are associated with invasive disease, whereas SSA, SPEC and SPEI are associated with noninvasive infections, although, as superantigen gene complement is linked to emm type, these associations are more likely to reflect emm-type prevalence in specific regions [44] . A European study showed that certain emm types expressing high levels of either SPEA or SPEC were associated with severe disease [12 ] . As GAS expresses an abundance of virulence factors, it seems unlikely that one specific virulence factor will be the predictor of severe disease, although a capacity to upregulate toxin production in vivo may be important. Little is known about superantigen regulation, although levels seem to be greater in vivo than in vitro in broth culture [45] .
Superantigens have recently been discovered in subspecies of the animal pathogen Streptococcus equi [46 ,47] (Table 1) . These superantigens have considerable homology to those of GAS. SzeF shares 59% homology to GAS SPEH, and szeN and szeP share 49 and 34% homology to GAS SPEM and SPEL, respectively [47] . The interspecies homology suggests horizontal transfer has occurred and may contine to do so [47] . Interestingly, S. equi subsp. equi lacks CRISPR elements that protect bacteria from bacteriophage attack [46 ,48] . As gene transfer can occur via phage-associated transduction, lack of these domains also renders S. equi subsp. equi more 
Upregulation of virulence factors
This two-component regulatory system controls transcription of 15% of the group A streptococcus (GAS) genome, including many key virulence factors such as capsule, SpyCEP and SpeB [32, 33, 34 ].
Table 1 Classification of superantigens in streptococcal species
Streptococcal species Superantigens permissive to transduction. Indeed, superantigen genes are known to transfer between strains via transduction [49, 50] . These related organisms may hence provide an important source for evolution and acquisition of virulence by GAS [46 ] .
Rheumatic fever
Rheumatic fever is the leading cause of childhood heart disease globally [51] with more than 80 cases per 10 000 children in some developing countries [52] . It provides the greatest burden of all GAS diseases, causing 23 300 deaths annually [53] . It is clinically defined by inflammation of joints (arthritis), the heart and heart valves (carditis), central nervous system (chorea), skin (erythema marginatum) and subcutaneous nodules [30] . The disease classically follows GAS pharyngitis in children aged 5-15 [53] .
Rheumatic fever is canonically attributed to an autoimmune attack following GAS pharyngitis [53] . Paradoxically, the incidence of rheumatic fever is high in aboriginal populations where pharyngitis is rare, but GAS pyoderma is common [8] and cases of rheumatic fever following STSS have been reported [54] . Taken together, GAS pharyngitis may not always be a prerequisite for rheumatic fever or syndromes mimicking rheumatic fever. The mechanism of rheumatic fever onset remains unclear, but is thought to involve a combination of host and GAS factors including human HLA type [51, 54] and GAS immunogens such as M-protein [51] .
The implementation of effective antibiotic treatment regimes for tonsillitis in Europe and the USA significantly reduced the incidence of rheumatic fever [55] . Recently, however, there have been several outbreaks in distinct geographic areas and populations of the USA [4, 5] . Rheumatic fever remains a serious problem for indigenous populations in developing countries [9, 10, 56] . Lack of effective diagnosis in these areas coupled with a recurrence rate of nearly 40% despite the administration of effective antibiotics [9] highlights the need for an effective vaccine against GAS.
Macrolide resistance
Although GAS remains universally penicillin sensitive, macrolides such as erythromycin are commonly used firstline drugs against GAS in patients with b-lactam allergies. Recent studies demonstrate the prevalence of erythromycin-resistant strains is high, especially in certain countries. Work this year in several countries indicates resistance in approximately 5-20% of strains, whereas in China, resistance occurs in over 95% of strains [6, [57] [58] [59] [60] [61] [62] . Resistance is predominantly mediated by two distinct mechanisms. The first, or 'M-phenotype', elicits lowlevel protection against 14-membered and 15-membered macrolides, including erythromycin, but not lincosamides, such as clindamycin, or streptogramin B, and is mediated by a drug efflux pump, encoded by mefA [63] .
The second mechanism is mediated by methylase modification of the ribosome target site, encoded by erm(B) or erm(TR) [6] . Expression of either of these resistance mediators can be inducible or constitutive. These resistance mechanisms elicit high-level resistance against macrolides, lincosamides and streptogramin B, hence designated the MLS B phenotype. Inducible resistance (iMLS B ) is typically more common than the constitutiveresistant (cMLS B ) phenotype [64] , although a recent study in Spain found that following a recent surge in MLS B type infections, cMLS B became more prevalent [6] . Such changes are important to recognize in view of advice to include lincosamides, such as clindamycin, in therapeutic regimes for invasive infections. The existence of the MLS B phenotype underpins the hazards of single-agent therapy with clindamycin for severe disease.
This Spanish study of antibiotic resistance found that 18.6% of cases were erythromycin resistant overall, and of these, 37.4% had an M phenotype [6] . This work observed a reduced prevalence of erythromycin-resistant GAS since 2007, although whether this will be sustained is unclear.
Development of a group A streptococcus vaccine
The variable surface M-protein has been the focus of much vaccine research. Such vaccines elicit robust protective immune responses [65] . M-protein antigenic variability at the N-terminus makes developing a broadly protective vaccine challenging [7, 66 ] . A study of emmtype prevalence in Israel over the past decade indicates a 26-valent M-type vaccine which reached phase II trials would have been protective against only 60% of cases [17] , and only 20% of cases in the Northern Territory [67] . Others have developed hexavalent M-protein-based vaccines, and a vaccine using the more conserved C-terminus [68] [69] [70] [71] . The development of M-proteinbased vaccines has been hampered not only by antigenic variability but also by concerns regarding the potential role of M-protein-induced immunity in rheumatic fever pathogenesis [51] .
Alternative vaccines targeting conserved surface antigens have been suggested. SpyCEP, a conserved cell surface protease [40 ,41,72] , was originally discovered as a vaccine candidate by systematic identification and testing of GAS surface exposed proteins [73] . Such vaccines have been used for in-vivo studies, where protective immunity was induced against not only invasive GAS but also the related pathogen S. equi, which expresses a near identical protease [74] . Examination of human serum found that the antigenome of GAS includes antibodies against Spy-CEP as well as eight further uncharacterized conserved antigens [75 ] .
C5a peptidase, another surface-exposed GAS protease, has been suggested as a vaccine candidate. This protein is conserved between GAS and S. agalactiae, and hence elicits a robust immune response, protective against both GAS and S. agalactiae [7] .
The GAS pilus is a polymeric surface structure, important for GAS colonization. The major subunit of the pilus (pilin) is a variable protein whose variation provides the basis of T-typing, and may have potential as a vaccine [76, 77] . Immunization with a combination of pilin variants is reported to provide protection against a range of virulent GAS isolates. A 12-valent vaccine is predicted to be protective against 90% of cases [78] . Work investigating the structure of the minor subunits of these polymers has been undertaken, and further work may reveal novel vaccine targets [79] [80] [81] , although, like the M-protein, antigenic variability may preclude practical implementation of such vaccines. It seems likely that future research will focus on multiple cell wall antigens in a multicomponent vaccine designed to exploit the advantages of those antigens already identified, yet without the hazards of the variable M-protein N-terminus.
Conclusion
Invasive GAS remains a significant cause of morbidity and mortality globally. Numerous epidemiological studies have been performed to ascertain changes in serotype prevalence, bacterial virulence and antibiotic resistance. In the last year, our understanding of bacterial population genetics and the underlying causes of pathogenesis have developed considerably. Despite these advances, the need for a GAS vaccine protective against a broad range of invasive serotypes worldwide remains a major issue for GAS researchers.
